Arcturus Therapeutics Q4 Earnings Assessment
Benzinga Insights 8 months ago
Earnings
Arcturus Therapeutics (NASDAQ:ARCT) announced its Q4 earnings on Tuesday, March 3, 2026 at 04:01 PM.
Here's a breakdown of the earnings report.
Earnings
Arcturus Therapeutics missed estimated earnings by -25.61%, reporting an EPS of $-1.03 versus an estimate of $-0.82.
Revenue was down $15.57 million from the same period last year.
Past Earnings Performance
The company beat on EPS by $0.49 in the previous quarter, leading to a 1.25% drop share price change the next day.
Here's a look at Arcturus Therapeutics's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.98 | -0.96 | -1.10 | -0.49 |
| EPS Actual | -0.49 | -0.34 | -0.52 | -1.11 |
| Revenue Estimate | 14.18M | 20.59M | 23.35M | 44.64M |
| Revenue Actual | 17.15M | 28.30M | 29.38M | 22.77M |
To track all earnings releases for Arcturus Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.